Association between renin‐angiotensin antagonism and COVID‐19–related mortality in patients with essential hypertension: A single center, retrospective cohort study

Abstract There is conflicting evidence in select mouse models and humans that suggest angiotensin‐converting enzyme 2 expression is increased due to treatment with angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARBs). Given the wide range of conditions that these me...

Full description

Bibliographic Details

Published in:	The Journal of Clinical Hypertension
Main Authors:	Vijayvardhan Kamalumpundi, Shuntaro Kawasaki, Linhai Cheng, Erin E. Meyers, Elham Shams, Ologibe Ofori, Assim Eddin, Marcelo L. G. Correia
Format:	Article
Language:	English
Published:	Wiley 2024-09-01
Subjects:	ACE2 COVID‐19 hypertension renin‐angiotensin antagonism
Online Access:	https://doi.org/10.1111/jch.14869